---
title: "Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297825779.md"
description: "Acumen Pharmaceuticals, Inc., a biopharmaceutical company traded on NASDAQ under the symbol ABOS, based in Newton, Massachusetts, shared on September 2, 2026, that they will be involved in some investor conferences. The company focuses on creating new treatments to combat Alzheimer’s disease by targeting toxic soluble amyloid beta oligomers."
datetime: "2026-09-02T20:01:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297825779.md)
  - [en](https://longbridge.com/en/news/297825779.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297825779.md)
generator: "portal-rs"
---

# Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals, Inc., a biopharmaceutical company traded on NASDAQ under the symbol ABOS, based in Newton, Massachusetts, shared on September 2, 2026, that they will be involved in some investor conferences. The company focuses on creating new treatments to combat Alzheimer’s disease by targeting toxic soluble amyloid beta oligomers.

### Related Stocks

- [ABOS.US](https://longbridge.com/en/quote/ABOS.US.md)

## Related News & Research

- [BlackRock Inc. Makes New Investment in Acumen Pharmaceuticals, Inc. $ABOS](https://longbridge.com/en/news/298099843.md)
- [Acumen Pharmaceuticals to present at Cantor Global Healthcare Conference fireside chat](https://longbridge.com/en/news/297822980.md)
- [Massachusetts Dental Firm Hit With Class Action Lawsuit Over Data Breach Affecting 15,000,000 Patients](https://longbridge.com/en/news/298310849.md)
- [14:21 ETNew Poll Shows Ed Markey's Support Slipping in Deep Blue Massachusetts](https://longbridge.com/en/news/297947167.md)
- [MiniLuxe forms joint venture with Vera Vos-Lexmond for Mansfield, Massachusetts studio](https://longbridge.com/en/news/297904156.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**